Innate Pharma S.A. earnings per share and revenue

IPHA earnings per share for the last semiannual are -0.33 USD whereas the estimation was -0.27 USD which accounts for -25.46% surprise. Company revenue for the same period amounts to 8.40 M USD despite the estimated figure of 18.24 M USD. Estimated earnings per share for the next semiannual are -0.36 USD, and revenue is expected to reach 9.61 M USD. Also watch annual changes over time to get a bigger picture of IPHA earnings per share and revenue dynamics.